English
Aarti Pharmalabs Q1 Results
- BSE: 543748
- NSE: AARTIPHARM
- ISIN: INE0LRU01027
- Sector: Biotechnology & Drugs
BSE
740.85
-7.25 (-0.97%)
-7.25 (-0.97%)Volume11.57 K
Updated: Fri 12 Dec, 2025 | 15:41:15
NSE
740.45-7.45 (-1.00%)
-7.45 (-1.00%)Volume1.20 L
Updated: Fri 12 Dec, 2025 | 15:45:06
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Aarti Pharmalabs Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 313.74 | 440.97 | -28.85% | 479.20 | -34.53% |
| Depreciation/ Amortization | 22.79 | 22.82 | -0.10% | 20.17 | 13.01% |
| Operating Income | 72.45 | 122.81 | -41.01% | 76.29 | -5.04% |
| Net Income | 49.50 | 88.34 | -43.97% | 55.45 | -10.73% |
| Other Operating Expenses Total | 80.29 | 0.00 | 0.00% | 81.56 | -1.56% |
| Net Income Before Taxes | 65.45 | 114.62 | -42.89% | 73.68 | -11.16% |
| Total Revenue | 386.19 | 563.78 | -31.50% | 555.49 | -30.48% |
| Selling/ General/ Admin Expenses Total | 41.26 | 139.40 | -70.40% | 39.23 | 5.16% |
| Diluted Normalized EPS | 5.46 | 9.75 | -44.00% | 6.12 | -10.78% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.